|
HS Code |
953295 |
| Compound Name | 4-[1-Hydroxy-2-(Methylamino)Ethyl]Phenol 2,3-Dihydroxybutanedioate (1:1) |
| Synonyms | Epinephrine L-(+)-Tartaric acid salt; Adrenaline tartrate |
| Molecular Formula | C9H13NO3·C4H6O6 |
| Molecular Weight | 333.32 g/mol |
| Cas Number | 51-42-3 |
| Appearance | White to off-white crystalline powder |
| Solubility | Soluble in water |
| Storage Temperature | 2-8°C |
| Purity | ≥98% |
| Usage | Pharmaceutical intermediate, adrenergic agonist |
| Ph Of Solution | 3.0–4.0 (for 1% solution in water) |
| Melting Point | 169-173°C |
| Stability | Stable under recommended storage conditions |
| Hazard Class | Non-hazardous for transport |
| Ec Number | 200-104-3 |
As an accredited 4-[1-Hydroxy-2-(Methylamino)Ethyl]Phenol 2,3-Dihydroxybutanedioate (1:1) factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | A sealed amber glass bottle, labeled with chemical name and hazard warnings, containing 10 grams of 4-[1-Hydroxy-2-(Methylamino)Ethyl]Phenol 2,3-Dihydroxybutanedioate (1:1). |
| Shipping | This chemical is shipped in secure, compliance-approved packaging under controlled temperature conditions to prevent degradation. Proper labeling with hazard and handling instructions ensures safe transit. Shipping adheres to international chemical transport regulations, including documentation for handling hazardous materials, and tracking is provided for delivery confirmation. Suitable for laboratory or research use only. |
| Storage | Store 4-[1-Hydroxy-2-(Methylamino)Ethyl]Phenol 2,3-Dihydroxybutanedioate (1:1) in a tightly sealed container, protected from light and moisture, at 2–8°C (refrigerated). Ensure the storage area is well-ventilated and away from incompatible substances. Label the container clearly and handle using standard laboratory safety protocols, including gloves and eye protection, to prevent accidental exposure. |
Competitive 4-[1-Hydroxy-2-(Methylamino)Ethyl]Phenol 2,3-Dihydroxybutanedioate (1:1) prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615380400285 or mail to sales2@liwei-chem.com.
We will respond to you as soon as possible.
Tel: +8615380400285
Email: sales2@liwei-chem.com
Flexible payment, competitive price, premium service - Inquire now!
In the landscape of fine chemical manufacturing, producing 4-[1-Hydroxy-2-(Methylamino)Ethyl]Phenol 2,3-Dihydroxybutanedioate (1:1) takes more than batch records and precise reactor conditions. We draw on every hour we’ve spent scaling up syntheses, watching for subtle clues during crystallization, handling purification phases, and confirming batch consistency. Each gram tells part of a larger story—one marked by active involvement and attention to every technical challenge.
This compound, with its defined stoichiometry and sensitive functional groups, asks for something different than off-the-shelf pharmaceutical intermediates or generic specialty chemicals. In the laboratory, its two-fragment structure—one as a modified catecholamine, the other as a tartaric acid salt—unlocks solubility, stability, and reactivity properties that have pushed us to refine solvent choices, crystallization conditions, and drying protocols.
Commercializing 4-[1-Hydroxy-2-(Methylamino)Ethyl]Phenol 2,3-Dihydroxybutanedioate (1:1) starts by sourcing the cleanest starting materials—nothing less will do. Each shipment of phenol and tartaric acid arrives with its own set of analytical data; we verify before moving forward. Several stages of synthesis follow: controlled alkylation, reduction, and salt formation, with monitoring by thin-layer chromatography and NMR. We learned early that even small impurities from the methylamine can cause color changes in the final material. These observations informed a shift in our purification methods—from single-stage to multi-stage extractions and selective recrystallizations.
Specifications aren’t just targets. They’re the result of decisions honed over repeated batches—decisions based on chromatography peaks, moisture analysis, melting point consistency, and documented behavior under forced degradation. We’ve modified our model over the years in response to end-user feedback: denser lots for easier dissolution, tighter control on residual solvents, and rigorous optical purity reviews.
Some products can be blended, bulked, or substituted. Others fill a niche that rewards precision. 4-[1-Hydroxy-2-(Methylamino)Ethyl]Phenol 2,3-Dihydroxybutanedioate (1:1) fits the latter. Its dual structure, combining phenolic and amine functions with a balanced dihydroxybutanedioate counterion, provides stability and unique solvating characteristics. Typical catecholamine-based intermediates often leave users with stability headaches—oxidative browning, clumping during grinding, or crystalline growth failures. Through manufacturing experience, we addressed these pitfalls step by step.
For example, conventional salt forms of hydroxyphenyl-ethanolamines can fall apart under humidity swings. We’ve run stress tests—accelerated humidity, direct sunlight, repeated cycles of refrigeration and room temperature—just to watch for early signs of caking or decomposition. With this product, handled under proper storage, the shelf-life extends well beyond the comparable free-base or monoacid salts. Impossible to reach this level of reliability without continuous feedback from lab development benches, pilot plants, and packing teams.
Every drum that leaves the loading dock has a full paper trail not just for regulatory reasons, but because small fluctuations in water content or counterion ratio show up downstream. Pharmaceutical developers lean on us to provide further spectral data; analytical teams in research labs expect low baseline noise in HPLC chromatograms. Diagnostics firms request detailed impurity maps. Over the years, we added extra controls—monitoring color at 405 nm, evaluating particle size under laser diffraction, cross-checking every lot by two independent analysts. Our quality team shares bench space; they see what happens when you push the purification a little harder or cut it a little short.
These aren’t hypothetical concerns. If the dihydroxybutanedioate ratio slips, the pH of solutions during formulation shifts enough to ruin sensitive molecular assemblies downstream. Impurities left from incomplete neutralizations can interfere with enzyme-linked detection in diagnostics or alter reaction kinetics in chemical synthesis. The appreciation for detail grows from seeing repeat batches succeed under tight deadlines, not just from laboratory trial and error but from the feedback loop with those who use the product most.
Applications range across analytical chemistry, fine pharmaceutical work, and bioassay development. Our partners in the pharmaceutical sector look for this compound’s stable salt formation when building sensitive APIs. Diagnostic firms request our batches specifically for their role in enzyme calibration. We’ve seen this product used for reference standards in regulatory submissions, and in quality control settings inside high-throughput screening facilities.
In each case, different requirements emerge: rapid dissolution in aqueous buffers, resistance to browning on standing, and reproducible interaction in target assays. One research group highlighted a recurring batch effect in their competitor’s material—variable peaks during capillary electrophoresis. Conversations with their analytical chemists helped us change our drying and packaging protocols. Post-process nitrogen flushing, tighter liners, and even tweaking the ambient air-pressure in the filling line all played a role. These weren’t bureaucratic changes—they were direct responses to reports from end-users working on real-world timelines.
Chemical manufacturing doesn’t forgive shortcuts. Early scaling runs taught us that slight excess in tartaric acid might smooth crystallization but can leave unreacted acid behind, requiring more rigorous washing steps. Each specification line—be it water content, chiral purity, or spectroscopic signature—reflects not just a number but the back-and-forth of synthesis, purification, and customer feedback.
Heat management during neutralization displayed subtle effects on crystal habit, impacting flow in downstream blending. Noticed that changing the cooling rate yielded finer powder with shorter dissolution times in end-use applications—direct requests from analytical labs, where researchers don’t have hours to wait for complete dissolution before loading their systems. The laboratory troubleshooting became an essential part of the process cycle—applying real-time solutions backed by decades of chemical handling. Mistakes became data points, resolutions became new standards.
Lab-synthesized hydroxyphenyl-ethanolamine compounds often appear as hydrochloride or bisulfate salts. These variants display sharper melting points but readily draw moisture from the air, clumping into unusable masses if stored incorrectly. Manufacturers using alternative counterions face downstream challenges when workers encounter rougher particle morphology, higher static buildup, or increased bitterness during API taste-masking studies.
Switching to a dihydroxybutanedioate matrix solved several headaches—improved bulk handling, gentler dissolution characteristics, and greater stability across a temperature range encountered in real dispatch networks. It wasn’t an overnight discovery. We trialed batches, took feedback from formulation labs, compared stability in stress chambers, and only then consolidated the process into regular production. Even today, maintaining this control requires vigilance: tracking storage temperature, periodic re-testing of archived samples for color formation, and keeping an ear to the ground for reported anomalies.
Running a successful synthesis doesn’t stop at isolation. Our team’s experience shows that inter-batch consistency relies on more than endpoint titration and simple melting point confirmation. Dual-mode HPLC, full NMR assignment, and advanced mass spectrometry bring out possible by-products often invisible under traditional QC regimens. Identifying and removing these traces demands deliberate planning, not last-minute correction.
Our process audit logs stretch back years, correlating solvent selection, batch temperature profiles, and packing room humidity—and tracking final product stability under diverse scenarios. We don’t label these products with vague language; instead, we document every lot’s journey from raw material, through synthesis, purification, and packaging, to final dispatch. If a customer requests spectral overlays or comparison panels, we have the archive at hand, not stored in an inaccessible central system but maintained close to production for quick review.
Traceability isn’t a poster slogan—it comes from an ethos built by mistakes, corrections, and open doors to our most exacting users. This has shaped our entire model, emphasizing reproducibility and rapid, transparent feedback loops. The technical teams see value in direct lines to our analysts and plant supervisors; outcomes translate into increases in trust and a willingness to bring challenges back to us for resolution.
No synthesis remains static. Heating profiles, solvent grades, even the make and batch of glass filters impact the finished product. We invite feedback from every manufacturing, analytical, and downstream user group to evolve procedures. Ask any operator on our lines about a process improvement—from packaging material upgrades to real-time particle size monitoring—and the answer grows from spent time on routine batch reviews and equipment walkarounds.
Recently, we introduced more granularity to moisture monitoring pre-packing—deploying inline Karl Fischer titration instead of batch-after analysis. This adjustment, though minute, led to lower variability in shipping samples sent across humid climates. Packing staff advocated for double-seal containers; R&D teams followed up with periodic checks, and new training for line workers reinforced the rationale behind the change.
We refine batch process models when batch-to-batch purity shows micro-variation, digging deep into yield curves, adjusting buffering agents and batch times in the light of real feedback. Our approach thrives on the feedback and responsiveness to site-specific process data, not just head office targets. While the compound’s structure remains constant, conditions around processing, storage, and end-use never truly sit still. Adapting to these circumstances, actively rather than reactively, defines our difference as a direct manufacturer.
Much of the reliability associated with 4-[1-Hydroxy-2-(Methylamino)Ethyl]Phenol 2,3-Dihydroxybutanedioate (1:1) comes from seeing thousands of batches through to completion. We build an understanding of material quirks—from the faintest trace impurity affecting color stability, to the way the powder flows in packing funnels on rainy days. This kind of practical, hands-on familiarity can’t be matched by intermediaries for whom the production site remains an abstraction.
Surprises do arise. A change in one supplier’s batch for a raw material can ripple through to final pH or dissolution rates. We take these disruptions seriously, launching root cause investigations involving both floor and technical staff. Every reported issue—whether shipment container leak or crystallization anomaly—becomes a case study for how to recalibrate both machinery and oversight.
Waste management for this synthetic route isn’t a theoretical step. Recovered solvents enter controlled distillation cycles, and all waste acid or unreacted material runs through monitored neutralization lines. There are strict checks at each filtration phase, ensuring nothing drains or evaporates unregulated. Our compliance auditor and process engineers trade notes daily to streamline flows, and production staff propose adjustments based on what makes a difference to the environment and safety, not just regulation minimums.
Energy use arose as a topic of continuous improvement—heat recovery loops from solvent evaporation now channel residual energy back into utility supplies. These efforts matter, not as headlines or slogans, but as lived responsibilities, constantly checked against both external reports and employee-driven process improvement plans.
Input from regulatory experts, toxicologists, and client-side chemists outlines many of the improvements that find their way onto our production lines. Regular communication with these technical leads—both in writing and on facility tours—enables tighter safety data, supports smoother submissions, and provides early notice of shifting industry expectations. Material handling staff often relay specific use-case feedback: humidity resistance, reconstitution speed, and flowability.
There’s trust built when our team walks through the data, shares troubleshooting insights, and invites partners to participate in sampling and review sessions. Many reported improvements have come from these direct collaborations, far more than from anonymous surveys or distributor channel feedback alone. For this reason, we welcome not just performance validation but raw, direct commentary from scientific and practical users alike.
Decades of handling, modifying, and improving 4-[1-Hydroxy-2-(Methylamino)Ethyl]Phenol 2,3-Dihydroxybutanedioate (1:1) have shaped our identity as a manufacturer committed to both technical rigor and real-world demands. The ability to support varied industries comes from hands-on understanding, direct user engagement, and continuous willingness to learn from every batch, every report, every anomaly and resolution. No layer separates our technical team from their process or from the users relying on our material’s consistency.
Changes in application requirements, whether for trace-level impurity reduction, new analytical standards, or tough shipping demands, don’t spark chaos here—they challenge us to adapt and deepen our knowledge. Each adaptation grows out of a practical need observed on the production floor or reported across the supply chain. As regulations and technology shift, that practical, grounded experience remains the foundation of continued reliability for this and every other synthesized product emerging from our plant.
As always, we stand ready to engage directly: sharing technical details, hearing application experiences, and collaborating with every partner committed to quality chemical solutions, built from the manufacturing source outwards.